Sure, it is. And it's the job of everyone else who works at the company, invests in the company, or knows about the product and uses it. I don't leave it to IR - I tell people what I know when I think it may help.
They have recently hired a new person whose specialty is communicating with large investment funds about biotech. The fact that he went with Star is significant to me.